Notice of Extra -Ordinary General Meeting of the Company to be held on Friday, October 23, 2026.

Date: October 01, 2026 BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Fort, Mumbai –400001 Scrip Code: 541096 Subject: Notice of Extra-Ordinary General Meeting. Pursuant to Regulation 30 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that an Extraordinary General Meeting (EGM) of our Company is scheduled to be held on Friday, October 23, 2026 at 11:30 A.M through Video Conference (VC)/ Other Audio-Visual Means (OAVM) in accordance with relevant circular(s) issued by the Ministry of Corporate Affairs and Securities and Exchange Board of India. Please �ind enclosed The Notice of Extra-Ordinary General Meeting along with the Explanatory Statement. The Company has completed the delivery of Notice of Extra-Ordinary General Meeting by Thursday, October 01, 2026, through electronic mode, i.e. email to all the members of the Company whose e-mail IDs are registered with the Company / Depository Participant(s) the Registrar and Share Transfer Agent (R & T Agent). The Remote e-Voting will commence on Tuesday, October 20, 2026, at 09:00 a.m. IST and will conclude on Thursday, October 22, 2026, at 05:00 p.m. IST. This is for your information and records, and we request you to treat the same as compliance with the applicable provisions of the Listing Regulations. Thanking you, Yours faithfully, For Bharat Parenterals Limited Sharmin Soni Company Secretary & Compliance Of�icer ICSI Membership Number: A-75694 SDuebar: IMnevmitabteirosn, to attend the Extraordinary General Meeting (“EGM”) of Bharat Parenterals L imited (“the Company”) to be held on Friday, October, 23, 2026. You are cordially invited to attend the EGM of the Company scheduled to be held on Friday, October 23, 2026, at 11:30 a.m. (IST) through Video Conferencing (“VC”)/ Other Audio-Visual Means (“OAVM”). The notice convening the EGM is enclosed herewith. FoSrr e.Naose. oPfa pratirctuicliaprastion, key details regardinDge tthaeil smeeting are as follows: 1. Link for participation in https://www.evoting.nsdl.com/ EGM through VC Members may attend the EGM through VC by accessing the above link and by using the remote e-voting credentials. Please refer to the instructions of this Notice for further information. 2. Link for remote e-voting https://www.evoting.nsdl.com/ Friday, October 16, 2026 3. Cut-off date for e-voting Tuesday, October 20, 2026 at 9:00 a.m. (IST) 4. Time period for e-voting Starts onT hursday, October 22, 2026 at 5:00 p.m. (IST) Ends on Monday, August 26, 2026 5. Last date for publishing results of On or before the e-voting Adroit Corporate Services Private Limited 6. Contact details of Registrar and Share Transfer Agent (RTA) 18-20, Jafferbhoy Industiral Estate, 1st Floor, Makwana Road, Marol Naka, Andheri East, Mumbai, Maharashtra, 400059 ENmataiiol nIDal: Sinefcou@raitdierosi Dtceoprpoosirtaotery.c oLmim ited (NSDL) 7. Helpline number for e- voting Tel No. 022 - 48867000 Email: evoting@nsdl.com 8. Helpline number for VC For any assistance or support before or during Participation the EGM, members may contact the Company Email Id: cs@bplindia.in 9. Scrutiniser Details CS Jigar Trivedi (Membership No. A- 46488) Practicing Company Secretaries, Ahmdabad Email: csjigartrivedi@gmail.com 10. Company Contact details Email: cs@bplindia.in Tel No.: 02667-251679 / 251680 /9909928332 For Bharat Parenterals Limited Best Regards, S harmin Soni CSdo/m- pany Secretary & Compliance Officer Date Membership N o. Place : October 01, 2026 – A75694 : Vadodara Enclosed: 1. Notice of EGM 2. Instru ctions to vote electronically using NSDL e-voting system 3. Instructions fo r participation in EGM through VC Notice of Extraordinary General Meeting NOTICE is hereby given that Extraordinary General Meeting (“EGM”) of the members of Bharat Parenterals Limited (“the Company”) will be held on Friday, October 23, 2026 at 11:30 A.M (IST) through Video Conference (“VC”)/Other Audio-Visual Means (“OAVM”) to transact the following s1p. ecial bIsussuinaenscsee so: f Equity shares of the Company on preferential basis. “TRoE cSoOnLsiVdEeDr a nTdH ifA tThought �it, pass the following resolution as a Special Resolution: pursuant to the provisions of Sections 42, 62(1)(c) and all other applicable provisions, if any, of the Companies Act, 2013 and applicable rules and regulations made thereunder, including the Companies (Prospectus and Allotment of Securities) Rules, 2014, the Companies (Share Capital and Debentures) Rules, 2014 (including any amendment(s), statutory modi�ication(s) or re-enactment(s) thereof), (hereinafter referred to as the ‘Act’), in accordance with the provisions of the Memorandum and Articles of Association of the Company, the regulations issued by the Securities and Exchange Board of India (‘SEBI’), including the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended (the ‘SEBI LODR), SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended (the ‘SEBI ICDR’), the applicable provisions of the Foreign Exchange Management Act, 1999, including any amendment(s), statutory modi�ication(s), variation(s) or re-enactment(s) thereof (‘FEMA’), and all other applicable statutes, clari�ications, rules, regulations, circulars, noti�ications and guidelines issued thereunder from time to time by the Government of India, Ministry of Corporate Affairs (“MCA”), Reserve Bank of India, the SEBI, the Stock Exchanges, the jurisdictional Registrar of Companies, and such other statutory/regulatory authorities (hereinafter collectively referred to as “Regulatory Authorities”), and subject to such other approvals, permissions, sanctions and consents, as may be required and on such terms and conditions (including any alterations, modi�ications, corrections, changes and variations, if any, that may be stipulated while granting such approvals, permissions, sanctions and consents) by any regulatory authorities and which may be accepted by the Board of Directors of the Company (hereinafter referred to as ‘Board’ which term shall be deemed to include any duly constituted/ to be constituted Committee of Directors thereof to exercise its powers including powers conferred under this resolution), the approval of the members be and is hereby accorded to the Company to create, offer, issue and allot up to 9,12,759 (Nine Lakhs Twelve Thousand Seven Hundred and Fifty-Nine Only) equity shares, on a preferential basis to the following Proposed Allottees, who are Non Promoters of the Company, at a price of Rs. 1522.85 (One Thousand Five Hundred Twenty-Two Rupees and Eighty-Five Paise Only) per equity share of the face value of Rs. 10/- (Rupees Ten only) each fully paid-up of the Company (including a premium of Rs. 1512.85 per equity share), (the Preferential Issue) being the price not less than the price determined in accordance with Chapter V of the SEBI ICDR (‘Floor Price’) as on the Relevant Date (i.e., September 23, 2026, being the date 30 days prior to the date of this Extraordinary General Meeting) determined in accordance with applicable law, aggregating to a total cash consideration of Rs. 138,99,95,043.15 (One Hundred Thirty-Eight Crore Ninety-Nine L akh Ninety-Five Thousand Forty-Three Rupees and Fifteen Paisa Only). Name of Proposed Allottees (Non-Promoters) Name of Proposed Allottees No. of Equity Consideration shares (INR) Sr. proposed to be No. allotted 1 WHITEOAK CAPITAL INDIA OPPORTUNITIES FUND 3,02,065 45,99,99,685.25 2 AURUM RISING INDIA FUND 1,64,165 24,99,98,670.25 3 WHITEOAK CAPITAL EQUITY TRUST - WHITEOAK CAPITAL EQUITY FUND II 1,31,332 19,99,98,936.20 4 ASHOKA INDIA EQUITY INVESTMENT TRUST PLC 80,631 12,27,88,918.35 5 WHITEOAK CAPITAL MULTI CAP FUND 45,966 6,99,99,323.10 6 INDIA ACORN FUND LTD 37,127 5,65,38,851.95 7 PERPETUITY HEALTH TO WEALTH (H2W) RISING FUND 36,116 5,49,99,250.60 8 WHITEOAK CAPITAL EQUITY FUND 26,266 3,99,99,178.10 9 SOAR WEALTH MANAGERS LLP 19,699 2,99,98,62 [Showing first 8,000 characters — download PDF for full document]